Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
Oakley Meta Vanguard review : fantastic AI running glasses linked to Garmin
3/11/2025
‘The silence allows me to hear every flurry of falling snow’ : walking in Switzerland’s hidden valley
3/11/2025
HMRC gave a refund from my tax account to fraudster making repayment claim
3/11/2025
Dining across the divide : ‘He looked like a typical Green voter – long hair, laid-back, that sort of thing’
2/11/2025
This is how we do it : ‘My cancer is terminal, but sex is its own form of healing’
2/11/2025
Tired all the time ? There may be a simple reason for that
2/11/2025